The overall goal of this proposal is to provide the resources and experiences that will allow the applicant to develop into a methodologically sophisticated, independent clinical investigator pursuing a research agenda directed at the effects of alcohol use and other comorbidity on the progression of HIV disease. This long term goal will be attained through the mentored completion of a study designed to improve tailoring of HIV treatment strategies to alcohol using populations. Using a large, ongoing prospective observational cohort (the Veterans Administration Cohort Study) the applicant will analyze the associations of alcohol use with short- and long-term efficacy of Highly-Active Anti-Retroviral Therapy (HAART). These associations will then be used in a computer simulation that will explore questions that clinical trials are not well suited to answer. The particular treatment questions that will be examined in this proposal are (1) how much life expectancy would be increased by treating hazardous or harmful patterns of alcohol consumption (2) what clinical parameters (CD4 and/or viral load) are the most appropriate thresholds for starting HAART, (3) what clinical parameters are the most appropriate thresholds for switching HAART upon regimen failure. The skills necessary to accomplish the above objectives and become an independent researcher will be accomplished through a series of classes, seminars, and mentored, structured reading and tutorials directed at specific areas of research related to the research proposal. The centerpiece of career development activities will be the K30 supported Clinical Research Training Program at the University of Pittsburgh which leads to a Masters Degree in Clinical Research. This program will be augmented through substantial time with internationally renowned experts and courses outside the Masters Degree program with specific applicability to important subject domains in the proposal, such as measurement of alcohol use and its consequences, measurement of adherence patterns and their correlates, survival analysis, regression analysis with time-dependent covariates, and algorithm design. My primary mentor, Mark S. Roberts, MD, MPP, an expert in medical decision sciences, together with my co-mentor, Amy Justice, the Principle Investigator of the Veterans Administration Cohort Study, will provide weekly feedback and supervision to help me accomplish these objectives.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Mentored Patient-Oriented Research Career Development Award (K23)
Project #
5K23AA014483-05
Application #
7279902
Study Section
Special Emphasis Panel (ZAA1-BB (15))
Program Officer
Roach, Deidra
Project Start
2003-09-01
Project End
2009-08-31
Budget Start
2007-09-01
Budget End
2009-08-31
Support Year
5
Fiscal Year
2007
Total Cost
$152,982
Indirect Cost
Name
Yale University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Braithwaite, R Scott; Fiellin, David A; Nucifora, Kimberly et al. (2010) Evaluating interventions to improve antiretroviral adherence: how much of an effect is required for favorable value? Value Health 13:535-42
Braithwaite, R Scott; Roberts, Mark S; Goetz, Matthew Bidwell et al. (2009) Do benefits of earlier antiretroviral treatment initiation outweigh harms for individuals at risk for poor adherence? Clin Infect Dis 48:822-6
Braithwaite, R Scott; Goulet, Joseph; Kudel, Ian et al. (2008) Quantifying the decrement in utility from perceived side effects of combination antiretroviral therapies in patients with HIV. Value Health 11:975-9
Braithwaite, R Scott; Conigliaro, Joseph; McGinnis, Kathleen A et al. (2008) Adjusting alcohol quantity for mean consumption and intoxication threshold improves prediction of nonadherence in HIV patients and HIV-negative controls. Alcohol Clin Exp Res 32:1645-51
Braithwaite, R Scott; Roberts, Mark S; Chang, Chung Chou H et al. (2008) Influence of alternative thresholds for initiating HIV treatment on quality-adjusted life expectancy: a decision model. Ann Intern Med 148:178-85
Braithwaite, R Scott; Concato, John; Chang, Chung Chou et al. (2007) A framework for tailoring clinical guidelines to comorbidity at the point of care. Arch Intern Med 167:2361-5
Braithwaite, R Scott; Rosen, Allison B (2007) Linking cost sharing to value: an unrivaled yet unrealized public health opportunity. Ann Intern Med 146:602-5
Braithwaite, R Scott; Shechter, Steven; Chang, Chung-Chou H et al. (2007) Estimating the rate of accumulating drug resistance mutations in the HIV genome. Value Health 10:204-13
Braithwaite, R Scott; Kozal, Michael J; Chang, Chung Chou H et al. (2007) Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies. AIDS 21:1579-89
Braithwaite, R S; Conigliaro, J; Roberts, M S et al. (2007) Estimating the impact of alcohol consumption on survival for HIV+ individuals. AIDS Care 19:459-66

Showing the most recent 10 out of 15 publications